Homburger advised Miller Insurance on the deal. Miller, the leading independent specialist (re)insurance broker, acquired the Zug-based reinsurance capital advisory business 4809 Brokers AG. The acquisition...
Miller Insurance’s Acquisition Of 4809 Brokers AG
TOLREMO Therapeutics AG’s CHF34.1 Million Series A Financing Round
Homburger advised TOLREMO therapeutics AG on the extension of its Series A financing round. TOLREMO therapeutics AG has completed its Series A financing, bringing the total amount...
Crown Packaging European Division GmbH’s Acquisition of Helvetia Packaging AG
Homburger AG has acted as Swiss counsel to Crown Packaging European Division GmbH on this transaction. Crown Holdings, Inc., a leading global supplier of rigid packaging...
Ironwood Pharmaceuticals’ $1 Billion Acquisition of VectivBio Holding
Advestra and Latham & Watkins advise Ironwood. Homburger AG serves as legal and tax advisor to VectivBio on the transaction. Goodwin advises Centerview Partners. VectivBio Holding...
OC Oerlikon’s Acquisition of Riri
Lenz & Staehelin advised the selling shareholders of RIRI Group in this transaction. Homburger advised OC Oerlikon. Oerlikon, a global innovation provider for surface engineering, polymer...
Global Blue’s $225 Million Growth Equity Investment From Certares and Knighthead
Simpson Thacher represented Global Blue on the deal. Homburger advised Certares Opportunities LLC and Knighthead Opportunities Capital Management, LLC. Niederer Kraft Frey advised Global Blue and...
CSL’s A$16.4 Billion Acquisition of Vifor Pharma
Homburger AG, Bär & Karrer, Simpson Thacher & Bartlett LLP, and Allens acted as joint legal advisors to CSL. PJT Partners, BofA Securities and Goldman Sachs...
Jenoptik’s Acquisition of Berliner Glas Medical and SwissOptic
Homburger advised ASML on the deal. Walder Wyss has advised JENOPTIK, together with White & Case. ASML Holding NV (NASDAQ: ASML) announced that it has agreed...
anthera Pharmaceuticals’ CHF 15 Million Private Convertible Bonds And CHF 10 Million Exchangeable Notes
Homburger advised Santhera in this matter. Santhera Pharmaceuticals annouced a strengthening of its capital structure via placement of private convertible bonds of CHF 15 million and upsizing of...
Santhera Pharmaceuticals’ CHF 20 Million Shares Private Placement
Pestalozzi advised H.C. Wainwright on the deal. Homburger advised Santhera. Santhera Pharmaceuticals, a Swiss specialty pharmaceutical company focused on the development and commercialization of innovative medicines for rare neuromuscular...
On Holding AG’s Initial Public Offering at NYSE
Lenz & Staehelin advised On Holding AG on the deal. Homburger advised the underwriters. On Holding AG, a Swiss-based athletic shoe and performance sportswear company, successfully...
Molecular Partners’ $63.8 Million Initial Public Offering in The US and Listing on NASDAQ Close
Homburger advised Molecular Partners AG in the transaction, while Davis Polk and Advestra advised the joint book-running managers and representatives of the underwriters. Molecular Partners AG,...